For years, Europe’s pharmaceutical sector has warned about declining competitiveness. Today, according to Nathalie Moll, Director General of EFPIA, that concern has evolved into something far more urgent.

As the US and China accelerate their industrial and innovation strategies, Europe finds itself at a critical crossroads where decisions around regulation, investment, patient access, and industrial policy will shape not only the future of healthcare innovation, but also the region’s broader economic and strategic position in the world.

Read the full interview here.

Europe stands at a crossroads. In a world shaped by geopolitical tensions, economic fragmentation and accelerating global competition, the choices made today will determine Europe’s ability to compete, innovate and lead in the decades ahead.

Join us on 23 June in Brussels to engage in a forward-looking discussion on how Europe can turn today’s challenges into opportunities – and make the right choices for its future.

Register here.